Tianyin Pharmaceutical Co., Inc. Launches Advertising Program on China Central Television (CCTV) for its Xuelian Chongcao O...( CHENGDU China June 29 Asia-FirstC...),Health

CHENGDU, China, June 29 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE AMEX: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that it has engaged a major advertising firm to commence a marketing initiative for its Xuelian Chongcao Oral Liquid product that will include prominent, prime-time advertisements on China Central Television (CCTV), China's most famous television station, which is viewed by 98% of households throughout China.

The length of the advertisements varies from 5 to 15 seconds and will run 37 to 40 times everyday for 12 months. In addition to the program on CCTV, the advertising partner is launching an expanded TV advertising program in Shanxi, Tianjin and Yunnan province. In the next several months, Tianyin will launch the advertising program in various cities and provinces nationwide. Tianyin is utilizing an innovative commission based compensation structure with this firm that is aimed at building significant brand awareness and market share gains while minimizing the risk to Tianyin, by placing the burden of performance on its partner.

Tianyin received the official approval from the Chinese State Food and Drug Administration (SFDA) to produce Xuelian Chongcao Oral Liquid in two dosage forms, 90 ml and 150 ml back in October 2002. The retail prices of 90 ml and 150 ml are approximately $10 and $18, respectively; under typical use, these quantities provide 3 to 5 days of treatment, respectively. Xuelian Chongcao Oral Liquid is an Over-the-counter TCM drug that effectively replenishes Yang due to a Yang and Qi insufficiency of the kidney, and also improves overall energy. Tianyin will produce this product at its current facility and management expects this product to generate revenue of approxim
'/>"/>